TRINAV INFUSION SYSTEM: payments to doctors
Payments that named TRINAV INFUSION SYSTEM as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $3.9M
- Providers
- 1,953
- Transactions
- 9,631
- Average per transaction
- $405
The per-transaction average — $405 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,953 providers the average total is $1,995, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Trisalus Life Sciences, Inc. | $3,896,658 | 100.0% |